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Signaling downstream of the T cell receptor (TCR) is directly regulated by the dose and 
affinity of peptide antigen. The strength of TCR signaling drives a multitude of T cell 
functions from development to differentiation. CD8 T cells differentiate into a diverse 
pool of effector and memory cells after activation, a process that is critical for pathogen 
clearance and is highly regulated by TCR signal strength. T cells rapidly alter their gene 
expression upon activation. Multiple signaling pathways downstream of the TCR activate 
transcription factors, which are critical for this process. The dynamics between proximal 
TCR signaling, transcription factor activation and CD8 T cell function are discussed here. 
We propose that inducible T cell kinase (ITK) acts as a rheostat for gene expression. This 
unique regulation of TCR signaling by ITK provides a possible signaling mechanism for 
the promotion of a diverse T cell repertoire in response to pathogen.
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inTRODUCTiOn
T cells bind antigen through their T cell receptor (TCR), activating a signaling cascade that leads to 
proliferation, differentiation, and pathogen clearance. The affinity of a TCR for its cognate antigen 
has been directly linked to the regulation of thymic selection and the T cell immune response. Upon 
receptor activation, tyrosine kinases are phosphorylated, creating signaling complexes at the plasma 
membrane that activate downstream signal transduction pathways. In response to activation, the T 
cell reorganizes its cytoskeleton, changes its metabolism, and alters its gene expression. This review 
focuses on the signaling pathways that contribute to changes in gene expression. The three main 
pathways activated through the TCR that control transcription are the MAPK, NF-κB, and calcium 
pathways. These pathways dramatically alter the expression and nuclear localization of various 
transcription factors that directly regulate genes involved in T cell activation (1, 2).
T cells recognize peptide antigens displayed by the major histocompatibility complex (pMHC) 
on antigen-presenting cells (APCs). The interactions between the TCR and pMHC have been exten-
sively characterized in the context of thymic selection and in the immune response to infection (3). 
In response to viral infection, CD8 T cells recognize antigen from APCs in the lymphoid organs, 
undergo clonal expansion, migrate to the site of infection, kill infected cells, and then die by apop-
tosis. Some of the CD8 T cells will survive this population contraction to form a memory pool (4).
Because T cells are polyclonal and contain variable TCRs, they are able to recognize a wide variety 
of peptide ligands. These ligands can have variable binding affinities for the TCR, creating a range 
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of ligand-binding kinetics (5). This variability contributes to the 
process of graded TCR signaling, where altered peptide ligands 
(APLs) can generate different signaling outcomes depending on 
the binding kinetics of the TCR and pMHC. This review high-
lights recent advances in the field, which connect proximal TCR 
signaling and transcription factor activation to changes in CD8 
T cell function.
GRADeD TCR STiMULATiOn AnD SiGnAL 
TRAnSDUCTiOn
The effect of APLs on the proximal signaling events downstream 
of the TCR has been extensively examined. In the basal state, the 
ITAMs of the TCR zeta chains are phosphorylated and bound to 
inactive Zap70. The dwell time of an agonist–peptide interaction 
with the TCR is significantly longer than self-peptide interac-
tions, creating a higher probability that a CD8 coreceptor bound 
to active Lck can be recruited and bind pMHC. This interaction 
increases complex stability and creates an opportunity for Lck 
to activate Zap70 by first phosphorylating Y319, relieving the 
autoinhibited conformation. Further activation of other tyros-
ine residues increases Lck and Zap70 interactions and further 
initiates both kinases to create the downstream LAT signaling 
complex (6). These proximal signaling events are absolutely 
required for downstream TCR signal transduction (7, 8). Using 
an engineered mutant allele of Zap70, which is sensitive to a 
small molecule kinase inhibitor, a sharp threshold of signaling 
was observed downstream of the kinase. Using Nur77–GFP as a 
readout for TCR signaling, Zap70 was determined to be required 
for signaling and cell division. This requirement was independent 
of both the strength of the pMHC–TCR interaction and IL-2 (9).
Not all pathways downstream of the TCR are similarly affected 
by antigen avidity. The calcium signaling pathway has been shown 
to be disproportionately affected by weak antigen stimulation 
(10–12). The MAPK and NF-κB pathways, while activated by 
the TCR, have a threshold level of activation that is less affected 
by weak stimuli. The MAPK pathway starts with Ras activation 
and subsequently leads to downstream Erk activation and the 
formation of the transcription factor dimer AP-1. In T cells, Ras 
is activated downstream of the TCR by RasGRP or SOS. Initially, 
RasGRP is activated by binding diacylglycerol (DAG), a byprod-
uct of PtdIns(4,5)P2 (PIP2) cleavage, followed by phosphorylation 
by protein kinase c (PKC) at the plasma membrane. This process 
is dependent on TCR signal transduction and ultimately on 
activation of phospholipase C (PLCγ). PLCγ activation gradually 
increases the local concentration of RasGRP at the LAT signaling 
complex. While this initial signaling event is graded in nature, 
it rapidly triggers a positive feedback loop. SOS acts as the inte-
gration point in this feedback loop; through allosteric binding, 
SOS substantially increases the GTPase activity of RasGTP (13). 
This feedback loop ensures that low-affinity TCR ligation can 
trigger robust Ras activation. Indeed, a digital signal response is 
observed with p-Erk, with different affinity antigens triggering 
maximal pathway activation. CD69 was also observed to have this 
digital response and its expression was highly dependent on the 
MAPK pathway (13, 14).
A similar signaling effect was observed in the NF-κB pathway. 
Jurkat cells stimulated with different concentrations of anti-CD3 
antibody were able to activate T cells in a graded manner. However, 
looking at IκBα degradation, the pathway was digital in nature 
with cells forming a bimodal population (15). Using a mutant 
form of the OT-I TCR (bTMD) having intact antigen-binding 
capacity but dampened signaling, a defect in PKC recruitment 
to the immunosynapse was observed shortly after stimulation. 
This defect leads to impaired CD8 memory formation. However, 
only a signaling defect in the NF-κB pathway was observed down-
stream of the TCR suggesting that a small signaling defect in 
this pathway could impair CD8 differentiation (16). The diverse 
functions of NF-κB signaling downstream of the TCR have been 
extensively reviewed (17).
The quality of the calcium signaling response is highly sensitive 
to TCR antigen affinity. Specifically, the influx oscillation patterns 
of this cation are highly mutable (10, 11, 18, 19). Using calcium 
indicator dyes to measure changes in intracellular ion concentra-
tion, changes in both the amplitude and duration of calcium influx 
have been observed upon stimulation with antigens of different 
affinities (10, 19). Low-affinity pMHC does not trigger robust cal-
cium influx in multiple in vitro T cell experiments. This has been 
linked to the regulation of calcium egress from the endoplasmic 
reticulum, a process that is mediated by the inositol trisphosphate 
receptor (IP3R) (10). In CD4 T cells, the time of onset for calcium 
flux was directly proportional to the affinity of the antigen. Weaker 
pMHC stimulation also reduced the magnitude of the influx peak 
and the duration of the influx (11). Calcium oscillation patterns 
have been directly linked to nuclear signaling in T cells with a 
non-linear relationship between [Ca2+] and transcription factor 
activation observed (20). Specifically, high frequency oscillation 
drove both NFAT and NF-κB activation, whereas low frequency 
oscillation drove only NF-κB activation. This, combined with 
differences in nuclear dwell time (>15 m for NF-κB and <10 m 
for NFAT), accounts for variable pathway activation in response 
to changes in calcium influx (21).
The calcium-sensitive transcription factor NFAT is well known 
for its contribution to T cell activation, specifically through the 
production of IL-2 and prosurvival factors. NFAT-binding part-
ners are also critical for T cell activation. Recently, the genetic 
targets of NFAT were further characterized by comparing con-
structs that allowed or ablated binding with its most common 
partner, AP-1. A subset of genes critical for the promotion of 
CD8 T cell exhaustion were highly dependent on NFAT, with 
transcription occurring in the absence of AP-1 (22). The amount 
of time that NFAT spends inside the nucleus is critical for specific 
transcriptional targets. Using multiphoton intravital microscopy, 
the half-lives of NFAT nuclear import and export were calculated 
to be ~1 min for import and ~20 min for export. The tolerance 
gene Egr2 was sensitive to short low-affinity antigen stimula-
tion, while the effector gene Ifng needed prolonged high-affinity 
stimulation (23).
The signaling data suggest that certain factors like CD69 and 
IL-2 are digital in nature, while others like interferon regulatory 
factor 4 (IRF4) are analog in nature. The strength of TCR stimu-
lus, whether through increased dose or affinity of antigen, is not 
proportional to the output of the MAPK and NF-κB signaling 
FiGURe 1 | Gene expression outputs downstream of the TCR can be 
digital or graded in nature. Some genes are upregulated to a maximal level 
and the increase in antigen dose will increase the percentage of positive cells 
within a given population (digital), while other genes increase in expression in 
direct proportion to the antigen dose and affinity across the entire population 
(graded).
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pathways. However, the activation marker IRF4 is proportional 
to the strength of stimulus (Figure 1).
GRADeD TCR SiGnALinG AnD 
TRAnSCRiPTiOn FACTORS
In addition to the canonical transcription factors AP-1, NF-κB, 
and NFAT, which are activated by the TCR, CD8 T cells rely 
on a diverse set of transcription factors that drive different 
functions. Recently, the balance of Blimp-1, T-Bet, Bcl-6, and 
eomesodermin has been linked to changes in CD8 differentia-
tion with high TCR signal strength driving T-Bet and Blimp-1 
expression, leading to terminal effector differentiation (24–26). 
Changes in transcription have also been linked to TCR affinity, 
specifically the transcription factor IRF4 (27). While it shares 
homology with other family members like IRF3, Type 1 IFN does 
not regulate IRF4 (28). Rather, its expression is directly regulated 
by antigen receptors in both T cells and B cells. Undetectable 
in naive lymphocytes, IRF4 is rapidly upregulated by antigen 
stimulation and the magnitude of expression is proportional to 
the strength of stimulus (29). The NF-κB family transcription 
factor Rel directly regulates Irf4 at the promoter locus (30). In 
CD8 T cells, IRF4 expression directly impacts clonal expansion 
and viral clearance. Specifically, the amount of IRF4 expressed in 
the CD8 T cell contributed to the expansion of short-lived effec-
tor cells (SLECs) (31–33). These terminally differentiated T cells 
are critical for pathogen control and require robust proliferation 
before the whole population is eliminated through apoptosis. 
IRF4 contributes to SLEC functionality by regulating multiple 
genes associated with glycolysis (32, 34). CD8 T cells rapidly shift 
their metabolism in response to antigen and similar cancer cells, 
they use glycolytic pathways to increase glucose import providing 
energy and macromolecules for biomass expansion and division 
(35, 36). IRF4 can also act as a repressor and binds sites in genes 
associated with apoptosis and cell cycle inhibition, supporting 
its important role in T cell survival and expansion (33). Directly 
comparing Irf4+/− with Irf4−/− and WT mice, viral clearance and 
SLEC expansion were directly proportional to the maximum level 
of IRF4 expression. The haplosufficient mice had approximately 
twofold to fivefold less IRF4 production, a reduction that was 
mirrored in their ability to clear infection (31).
The frequent binding partner of IRF4, BATF, has also been 
linked to CD8 T cell expansion. However, unlike IRF4, the levels 
of expression are not as critical. The two transcription factors are 
regulators of T-bet and Blimp1 expression, the two transcrip-
tion factors that drive effector differentiation (37). Interestingly, 
BATF was determined to act as a “persistence detector” of antigen 
signaling. Maximum BATF-mediated effector differentiation was 
only triggered by durable antigen signaling. Late in the T cell 
response, BATF could also repress critical genes like perforin and 
granzyme B, dampening the late effector response (37).
Another factor associated with TCR affinity is Nur77, a tran-
scription factor primarily associated with apoptosis (38). Nur77 
is often used as a reporter for TCR activation with its expression 
proportional to antigen avidity. The amount of Nur77 expres-
sion correlates with thymic selection, with negatively selected 
thymocytes having higher levels than their positively selected 
counterparts (39, 40). Nur77 is rapidly upregulated after antigen 
stimulation, and its expression is dependent solely on TCR 
signaling. Using a Nur77–GFP reporter mouse, the levels of GFP 
were proportional to the affinity of TCR ligand in the OT-I model 
system, showing a graded expression similar to IRF4 (39).
iTK AnD GRADeD TCR SiGnAL 
STRenGTH
Downstream of Lck, the LAT signaling complex is critical for 
downstream signaling pathway activation. Inducible T cell 
kinase (ITK) is a Tec family tyrosine kinase, which is activated by 
Lck and phosphorylates PLCγ. Unlike its sister kinase Bruton’s 
tyrosine kinase (BTK), ITK’s expression is largely limited to T 
cells, and its catalytic activity is in the weak micromolar range. 
In resting T cells, ITK resides in the cytosol. Upon activation, 
the kinase is recruited to the plasma membrane through its 
pleckstrin homology (PH) domain, which binds PtdIns(3,4,5)P3 
(PIP3). ITK also associates with the LAT–SLP76 complex through 
its SH2 and SH3 domains, creating a signaling complex that is 
directly dependent on upstream Lck and Zap70 signaling. ITK 
is directly phosphorylated by Lck and subsequently undergoes 
cis-autophosphorylation. Then, ITK is able to phosphorylate the 
lipase PLCγ that cleaves PIP2 in the plasma membrane, generat-
ing the secondary messengers IP3 and DAG. These secondary 
messengers primarily activate the downstream MAPK, NF-κB, 
and calcium signaling pathways (41–43).
Unlike the upstream Src kinases, ITK is not required for T cell 
activation. Indeed, Itk-deficient T cells are capable of proliferation 
and cytokine production in response to antigen stimulation (44, 
45). Mice lacking ITK are also able to clear pathogens in multiple 
infection models (46–48). However, Itk-deficient T cells are not 
normal, and a diminished response is observed rather than an 
FiGURe 2 | iTK acts as a rheostat for the TCR signaling pathway. While the expression of genes like CD69 and IL-2 is not directly proportional to the signaling 
input at the TCR, other genes like IRF4 have a graded response where expression continues to increase with higher affinity TCR stimulation. High-affinity antigens 
increase the duration of TCR binding, increasing the stability of activated Lck and Zap70, which amplifies downstream signaling by creating a larger pool of activated 
LAT signaling complexes. This creates a larger pool of activated ITK, represented here for simplification without the other signaling components in the pathway. We 
propose that the calcium signaling pathway is uniquely sensitive to ITK and can provide a mechanism for graded IRF4 expression.
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ablated response. While the MAPK pathway is only modestly 
impaired in Itk-deficient T cells, the magnitude of calcium flux 
is greatly reduced in response to antigen (12). This reduction in 
signaling correlates with a reduction in CD8 clonal expansion 
in response to infection (49). A key set of experiments directly 
compared kinase dead mutants of Lck and ITK in activated T cells 
(50). While both mutants inhibited calcium flux in the T cells, the 
kinases had very different effects on the whole population. The 
Lck mutants ablated calcium signaling in a proportion of the T 
cells, while ITK mutants dampened the calcium response of each 
cell in the entire population. This suggests a digital regulation of 
calcium signaling through Lck and an analog regulation through 
ITK. We propose that ITK and the calcium signaling pathway 
are critical for maintaining the analog nature of this TCR output 
(Figure 2).
GRADeD TCR SiGnALinG AnD CD8 
T CeLL FUnCTiOn
CD8 T cell development and function have been studied using 
the OT-I transgenic mouse model. The OT-I TCR recognizes 
the SIINFEKL peptide (OVA), an antigen derived from chicken 
ovalbumin (51). These OT-I T cells are MHC class I restricted, 
creating a large population of naive CD8 T cells that recognize 
the Ova antigen. The OT-I model provides an excellent system to 
study TCR signal strength because of the exquisitely high-affinity 
OVA peptide ligand. APLs with single amino acid substitutions 
greatly reduce TCR-binding affinity while maintaining equivalent 
MHC-binding capacity. Scientists have also engineered a variety 
of pathogens to express these APLs, providing excellent infection 
models to study TCR signal strength in vivo. In the context of CD8 
T cell development in the thymus, graded TCR signal strength 
drives the balance between positive and negative selection, a 
process that can directly impact autoimmune disease (52–54).
A series of studies have looked at CD8 T cell activation in vivo 
in response to infection and have teased apart contributions 
between antigen interactions and environmental inflamma-
tory signals. While T cell expansion was directly proportional 
to antigen avidity, cytolytic function was more dependent on 
inflammatory signals (55, 56). Using peptide-pulsed dendritic 
cells with or without Listeria monocytogenes infection, granzyme 
B and IFN-γ production were only seen in the context of infec-
tion. However, IL-2 and the chemokine receptor CCR7 were 
regulated in the absence of inflammation, and their expression 
was directly proportional to the avidity of the antigen. The high-
affinity IL-2 receptor (CD25) was driven by both signals with its 
expression proportional to both dose and affinity of the stimulus 
(55, 57). These Listeria experiments show that certain aspects 
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of T cell function are driven by the affinity of the pMHC–TCR 
interaction, while others are driven by cytokine activation. Low-
affinity antigen stimulation downregulated CCR7 earlier than 
high-affinity stimulation and the T cells were able to migrate out 
of the periarteriolar lymphocyte sheaths (PALS) at an earlier time, 
creating a larger proportion of T cells in the blood and the red 
pulp of the spleen. The high affinity stimulated T cells retained 
CCR7 expression out to 4 days and did not migrate out of the 
PALS. Effects on T cell migration and tissue infiltration were also 
observed in the context of autoimmunity (57). In a model where 
membrane-bound ovalbumin (mOVA) is under the control of 
the rat insulin promoter (RIP), OT-I T cells were transferred into 
mice after immunization with high- and low-affinity peptide anti-
gen. Only T cells stimulated with high-affinity peptide were able 
to infiltrate the pancreas and migrate to the site of Ova antigen, a 
process that was dependent on the integrin VLA-4.
The altered expression in both magnitude and kinetics of 
CD25, CD69, and CCR7 shows that antigen affinity directly 
affects IL-2 signaling and lymph node egress. This suggests that 
T cells stimulated with high-affinity antigen are able to sequester 
more IL-2 from the environment and remain in the lymph node, 
thereby allowing them a longer time to receive stimulation. This 
delay in egress contributes to a more robust clonal expansion, a 
process that is directly proportional to antigen avidity. Signaling 
through the IL-2 receptor is required for CD8 memory forma-
tion (58). Mice lacking IL-2 receptors in mature CD8 T cells, 
mixed chimeras that retain a normal population of T regulatory 
cells, were able to mount a normal primary response to LCMV 
infection. However, the secondary response was impaired. 
Thus, IL-2 signaling is required during the primary response to 
produce a functional memory pool (59). IL-2 can also promote 
proliferation of T cells stimulated by low-affinity antigen. Using 
an in vitro coculture system of P14 and OT-I CD8 T cells, P14 T 
cells stimulated with high-affinity GP33 peptide could produce 
IL-2 and trigger increased proliferation in neighboring OT-I T 
cells that were stimulated with the low-affinity G4 peptide. The 
IL-2 is required within 20–30 h of antigen stimulation and PI3K 
signaling through the IL-2 receptor cooperates with TCR signal-
ing to promote cell cycle entry (60). IL-2 is not the only secondary 
signal that cooperates with TCR activation, a wide variety of 
costimulatory pathways interplay with graded TCR signaling to 
promote diverse CD8 T cell functions (61). The regulation of T cell 
memory has been extensively linked to a combination of graded 
TCR signaling and costimulation using multiple transgenic and 
pathogen models (24).
Affinity of the antigen has also been linked to regulation of 
asymmetric cell division with proximal daughter T cells becom-
ing SLECs (57, 62). High-affinity interactions led to a distinct 
progeny after the first division with proximal daughters contain-
ing the immunosynapse and increased glycolytic capacity. In con-
trast, low-affinity TCR interactions did not lead to this phenotype 
(57). Graded TCR signaling controls many aspects of CD8 T cell 
differentiation. The signaling mechanisms that connect graded 
TCR stimulation with these changes in differentiation while not 
completely understood have been extensively examined in the 
recent years.
COnCLUSiOn AnD FUTURe DiReCTiOnS
The data generated with the ITK knockout mice suggest that ITK, 
while not required for pathogen clearance, can act as a rheostat, 
capable of amplifying or reducing the magnitude of signaling 
downstream of the TCR. This tuning of signaling can have effects 
on multiple processes including T cell development and T cell 
differentiation in response to infection. Indeed, Itk-deficient 
mice have alterations in T cell development with an increase in 
innate-like T cells exiting the thymus (63). In response to LCMV 
infection, Itk-deficient CD8 T cells had a defect in expansion, 
very similar to the defect that was seen in Irf4 haplosufficient mice 
(31, 49). Also, expression of IRF4 is highly dependent on ITK 
activity with a dose proportional reduction observed between 
IRF4 and ITK inhibition. Our hypothesis is that certain factors 
like IRF4 depend on TCR signaling for expression, which can 
be fine-tuned by the rheostat ITK. This can lead to changes in 
CD8 effector function, providing a link between ITK and CD8 T 
cell fate. One possible mechanism for this unique level of control 
is through the calcium pathway. Teasing apart contributions of 
the different signaling pathways on graded transcription factor 
expression remains to be done. Directly measuring calcium ion 
flux in single T cells in the context of graded TCR signaling 
in  vivo will determine whether calcium signaling alone drives 
the rheostat activity of ITK. It is also unknown what other genes 
are regulated in a similar fashion as IRF4. Future experiments 
will further elucidate the mechanisms connecting graded TCR 
signaling to changes in transcription and CD8 T cell function.
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